Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MID Labs

Explore full profile

Excel at providing quality and innovative ophthalmic products that benefit the patient

San Leandro, United StatesFounded 1981Health Tech & Medtech
Valuation $250–500M Last recorded · 2014
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MID Labs and the history behind them.

About MID Labs

MID Labs, founded by Dr. Carl Wang in 1981, is a pioneering company in the field of ophthalmic surgical devices, specifically focusing on vitreoretinal surgery. Based in the San Francisco Bay Area, MID Labs has established itself as a global leader in the development and manufacture of advanced surgical instruments. The company's product line includes Vitreous Cutters, Bi Blade Vitreous Cutters, and the Single Step Cannula Insertion System, which are distributed in over 30 countries worldwide. MID Labs serves ophthalmic surgeons and healthcare providers, offering cutting-edge solutions that enhance surgical precision and patient outcomes. The company operates in the medical device market, with a business model centered around the research, development, and sale of high-quality surgical instruments. Revenue is generated through direct sales to healthcare institutions and partnerships with distributors. MID Labs is committed to preventing blindness caused by injuries and diseases such as diabetes, and its products have been used to help more than one million people globally. The company prides itself on its values of collaboration, initiative, integrity, and precision.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1981
Headquarters
San Leandro, United States
Employees
34
Open positions
3
Dealroom signal
26.3/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Surgery
Business model
Manufacturing
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Oct 2014 $51M $204M OrbiMed · Frontline BioVentures · Yuansheng BioVenture —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

MID Labs website traffic

Latest recorded traffic for MID Labs is 130 monthly website visits, up 62.5% over the last three months.

Latest monthly visits130 3-month web change+62.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • OrbiMed
  • Frontline BioVentures
  • Yuansheng BioVenture
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MID Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MID Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.